Erik Schrumpf Selected Research

Bile Duct Diseases (Bile Duct Disease)

1/2018	Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
1/2017	norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
11/2014	Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
1/2011	TGR5 sequence variation in primary sclerosing cholangitis.
8/2010	Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik Schrumpf Research Topics

Disease

29	Sclerosing Cholangitis 01/2018 - 03/2002
11	Neoplasms (Cancer) 01/2017 - 05/2004
8	Cholangiocarcinoma 05/2015 - 09/2003
5	Bile Duct Diseases (Bile Duct Disease) 01/2018 - 08/2010
4	Ulcerative Colitis 01/2017 - 03/2010
3	Liver Diseases (Liver Disease) 01/2017 - 03/2006
3	End Stage Liver Disease 04/2016 - 09/2003
3	Inflammation (Inflammations) 05/2013 - 08/2004
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 05/2013
2	Disease Progression 04/2016 - 10/2010
2	Pathologic Constriction (Stenosis) 10/2010 - 11/2005
2	Adenocarcinoma 05/2008 - 10/2006
2	Fibrosis (Cirrhosis) 05/2006 - 08/2004
1	Cholestasis 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 05/2007
1	Infections 05/2006
1	Intravenous Substance Abuse 05/2006
1	Colorectal Neoplasms (Colorectal Cancer) 05/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2012
3	Bile Acids and Salts (Bile Acids)IBA 01/2011 - 03/2010
3	GTP-Binding Proteins (G-Protein)IBA 01/2011 - 03/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 11/2014
2	BilirubinIBA 04/2016 - 09/2003
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 09/2012 - 05/2004
2	Natural Killer Cell ReceptorsIBA 01/2008 - 05/2007
1	AntibodiesIBA 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	AcidsIBA 01/2017
1	Alkaline PhosphataseIBA 04/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2011
1	Interleukin-2 (IL2)IBA 06/2011
1	Peptides (Polypeptides)IBA 06/2011
1	DNA Glycosylases (DNA Glycosylase)IBA 07/2009
1	Mutant Proteins (Protein, Mutant)IBA 07/2009
1	Interleukin-6 (Interleukin 6)IBA 04/2008
1	LigandsIBA 05/2007
1	Immunoglobulins (Immunoglobulin)IBA 05/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2006
1	Pregnane X ReceptorIBA 09/2006
1	Immunoglobulin G (IgG)IBA 05/2006
1	SteroidsIBA 11/2005
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 08/2004
1	Matrix Metalloproteinases (MMPs)IBA 08/2004

Therapy/Procedure

18	Liver Transplantation 01/2018 - 03/2002
4	Therapeutics 01/2017 - 10/2010
3	Transplantation 06/2015 - 05/2004
1	Cholecystectomy 05/2008
1	Contraindications 05/2004